Sign in

CIK 0000887359 · Large accelerated filer

Vericel Corp

Sign in to watch
Ticker
VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
MI
Entity type
operating
EIN
943096597
Phone
6175885555
Business address
25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
Former names
AASTROM BIOSCIENCES INC
  1. 4 Open-market sale CFO and VP, Corp. Development sold 8,711 shares at an average $17.18 ($149,627)
  2. 4 Open-market sale Director sold 22,500 shares at $16.83 ($378,693)
  3. 4 Open-market sale CFO and VP, Corp. Development sold 15,625 shares at $16.81 ($262,656)
  4. 4 Open-market sale Director sold 8,500 shares at $17.75 ($150,908)
  5. 4 Open-market sale CFO and VP, Corp. Development sold 15,000 shares at $15.90 ($238,500)
  6. 4 Open-market sale President and CEO sold 50,000 shares at $15.39 ($769,500)
  7. 4 Open-market sale CFO and VP, Corp. Development sold 15,000 shares at $12.65 ($189,750)
  8. 4 Open-market sale President and CEO sold 75,000 shares at $15.02 ($1,126,500)
  9. 4 Open-market sale CFO and VP, Corp. Development sold 15,000 shares at $12.35 ($185,250)
  10. 4 Open-market sale Director sold 9,000 shares at $12.03 ($108,270)
  11. 4 Option exercise CFO and VP, Corp. Development acquired 112,481 shares (option exercise)
  12. 4 Open-market sale Director sold 30,000 shares at $12.06 ($361,800)
  13. 4 Open-market sale President and CEO sold 28,886 shares at an average $14.01 ($404,604)
  14. 4 Open-market sale Chief Operating Officer sold 34,183 shares at an average $13.04 ($445,854)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 18 of 32 · 637 filings